said it was evaluating the FDA letter. The drug is sold outside the United States by Germany's Bayer AG (BAYGn. DE) and is available in more than 50 countries under the brand name Nebido. Endo licenses Aveed from Bayer. Jefferies & Co analyst Corey Davis...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 3-US FDA declines to approve Endo testosterone drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account